Beijing Hotgen Biotech Co Ltd (688068) — Cash Flow Reinvestment Rate
Beijing Hotgen Biotech Co Ltd (688068) has a Cash Flow Reinvestment Rate of 4.82x as of September 2025, reinvesting CN¥14.73 Million (capex CN¥14.73 Million ) from operating cash flow of CN¥3.05 Million. See Beijing Hotgen Biotech Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Hotgen Biotech Co Ltd Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Beijing Hotgen Biotech Co Ltd across 7 annual periods. For the full cash flow conversion analysis, see how efficiently does Beijing Hotgen Biotech Co Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Beijing Hotgen Biotech Co Ltd (2016–2022)
Year-by-year capital reinvestment analysis for Beijing Hotgen Biotech Co Ltd. See Beijing Hotgen Biotech Co Ltd (688068) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.73x | CN¥1.70 Billion | CN¥978.75 Million | CN¥565.21 Million | ▲ +159.5% |
| 2021 | 0.67x | CN¥1.77 Billion | CN¥2.64 Billion | CN¥398.86 Million | ▼ -92.9% |
| 2020 | 9.35x | CN¥1.54 Billion | CN¥164.62 Million | CN¥172.27 Million | ▼ -87.6% |
| 2019 | 75.11x | CN¥1.45 Billion | CN¥19.37 Million | CN¥88.48 Million | ▲ +193.5% |
| 2018 | 25.59x | CN¥1.41 Billion | CN¥55.04 Million | CN¥42.00 Million | ▲ +330.0% |
| 2017 | 5.95x | CN¥136.61 Million | CN¥22.95 Million | CN¥69.05 Million | ▲ +546.2% |
| 2016 | 0.92x | CN¥41.95 Million | CN¥45.54 Million | CN¥21.18 Million | — |